Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes Xavier LeleuThomas MartinPaul G. Richardson Review Article Open access 09 August 2022 Pages: 2123 - 2137
Rituximab plus cladribine versus R-CHOP in frontline management of marginal zone lymphoma in China: a propensity-score matched multicenter study Yawen WangJiadai XuPeng Liu Review Article 20 July 2022 Pages: 2139 - 2148
Cut-off values for diagnosis of G6PD deficiency by flow cytometry in Thai population Anchalee ThedsawadWanchai WanachiwanawinChattree Hantaweepant Original Article Open access 15 July 2022 Pages: 2149 - 2157
Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura Jenna BrownBindu PotugariShruti Chaturvedi Original Article 06 August 2022 Pages: 2159 - 2167
Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study Alexander RöthWilma BarcelliniIlene C. Weitz Original Article Open access 23 August 2022 Pages: 2169 - 2177
Activation of signaling pathways in models of t(6;9)-acute myeloid leukemia Claudia ChirichesDilawar KhanMartin Ruthardt Original Article Open access 08 August 2022 Pages: 2179 - 2193
CD277 agonist enhances the immunogenicity of relapsed/refractory acute myeloid leukemia towards Vδ2+ T cell cytotoxicity Tianhui DongNing WuJiangying Liu Original Article 03 August 2022 Pages: 2195 - 2208
Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis Shih-Chiang LinChi-Yuan YaoShang-Ju Wu Original Article Open access 30 August 2022 Pages: 2209 - 2218
Effect of thrombopoietin receptor agonist on health-related quality of life and platelet transfusion burden for patients with myelodysplastic syndromes: a systematic review and meta-analysis Kai WangYacong ShaoYongming Zhou Original Article 17 August 2022 Pages: 2219 - 2229
Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera Ana TrigueroAlexandra PedrazaOn behalf of the MPN Spanish Group (GEMFIN) Original Article Open access 30 August 2022 Pages: 2231 - 2239
Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory Sandrine SauguesCéline LambertMarc G. Berger Original Article 30 August 2022 Pages: 2241 - 2255
Bosutinib-induced late-onset severe liver injury preceded by eosinophilia Naoki WatanabeTomoiku TakakuMiki Ando Original Article 25 August 2022 Pages: 2257 - 2262
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia A. LunaL. Pérez-LamasV. García-Gutiérrez Original Article Open access 23 August 2022 Pages: 2263 - 2270
Prognostic value and computer image analysis of p53 in mantle cell lymphoma Yue-Hua ZhangLi-Min GaoWei-Ping Liu Original Article 03 August 2022 Pages: 2271 - 2279
Hemophagocytic lymphohistiocytosis in HIV-associated lymphoproliferative disorders Pascal MigaudMarkus MüllerHartmut Stocker Original Article 19 August 2022 Pages: 2281 - 2287
Clinical characteristics and treatment of NK/T-cell lymphoma–associated HLH Guangqiang MengJingshi WangZhao Wang Original Article 24 August 2022 Pages: 2289 - 2296
Practice patterns and outcomes of hemophagocytic lymphohistiocytosis in adults: a 2-decade provincial retrospective review Jennifer CrodenLisa BilstonHaowei Linda Sun Original Article 17 August 2022 Pages: 2297 - 2306
Amyloidosis and COVID-19: experience from an amyloid program in Canada Ellen LewisNowell FineVictor H. Jimenez-Zepeda Original Article 26 August 2022 Pages: 2307 - 2315
Scheduled removal of central venous catheters (CVC) to prevent CVC-related bloodstream infections in patients with hematological disease or autologous stem cell transplantation: a registry-based randomized simulation-study Jens PanseDaniela TölleEnrico Schalk Original Article Open access 17 August 2022 Pages: 2317 - 2324
Efficacy and safety of a colostrum- and Aloe vera-based oral care protocol to prevent and treat severe oral mucositis in patients undergoing hematopoietic stem cell transplantation: a single-arm phase II study Monica GubertiStefano BottiMaria Grazia De Marinis Original Article Open access 03 August 2022 Pages: 2325 - 2336
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies Ferenc MagyariLászló Imre PinczésÁrpád Illés Original Article Open access 14 July 2022 Pages: 2337 - 2345
Rapid and deep response to avapritinib in heavily treated acute myeloid leukemia with t (8;21) and KIT mutation Jia YinFeng ZhuSu-Ning Chen Letter to the Editor 29 June 2022 Pages: 2347 - 2350
Forodesine maintenance therapy for newly diagnosed peripheral T-cell lymphoma: a single-institutional, observational, retrospective analysis Masaki IinoTomoya SatoNobuyuki Takayama Letter to the Editor 25 June 2022 Pages: 2351 - 2352
Effective treatment with polatuzumab vedotin of relapsed and refractory primary cutaneous diffuse large B-cell lymphoma leg type Satoko OkaKazuo OnoMasaharu Nohgawa Letter to the Editor 09 August 2022 Pages: 2353 - 2354
Whole exome sequencing identifies a novel SPTB frameshift mutation causing hereditary spherocytosis in the Chinese population Xiao-Dong LiuKun YangJing-Yuan Huang Letter to the Editor 21 June 2022 Pages: 2355 - 2357
A novel WNK1::PDGFRB fusion gene in myeloid neoplasm with eosinophilia: a case report Tiantian WangJunjie CaoYing Lu Letter to the Editor 27 June 2022 Pages: 2359 - 2361
Venous thromboembolism after COVID-19 mRNA vaccination Philip Murphy Letter to the Editor 02 July 2022 Pages: 2363 - 2363
First Latin America report on the diagnostic utility of the study of the MYD88 L265P gene mutation in patients with Waldenström Macroglobulinemia F. GiulianiM. A. PavlovskyJ. J. Castillo Letter to the Editor 07 July 2022 Pages: 2365 - 2367
Co-existence of a novel translocation t(11;22)(q23;q12.1) with PML-RARA in acute promyelocytic leukemia: a case report Woo Yong ShinJung-Ah KimRojin Park Letter to the Editor 02 July 2022 Pages: 2369 - 2371
Can we restart the rituximab after remission of rituximab-induced interstitial lung disease in malignant lymphoma? Dongdong ZhangYidi HanYouhong Dong Letter to the Editor 01 July 2022 Pages: 2373 - 2375
Prognostic impact of switching from cyclosporine to corticosteroids early after single cord blood transplantation Kosuke TakanoTakaaki KonumaYasuhito Nannya Letter to the Editor 14 July 2022 Pages: 2377 - 2378
Non-traumatic splenic rupture after discontinuation of zanubrutinib and venetoclax therapy in relapsed/refractory diffuse large B-cell lymphoma Yao QinKai ShenHongbing Ma Letter to the Editor 12 July 2022 Pages: 2379 - 2380